L-368,899 HYDROCHLORIDE
L-368,899 HYDROCHLORIDE
L-368,899 HYDROCHLORIDE 性质
| 储存条件 | −20°C |
|---|---|
| 溶解度 | H2O：20 mg/mL，可溶 |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 水溶解性 | H2O: soluble 20mg/mL |
| InChIKey | GIUFQWFJHXXXEQ-SWJTYIIKSA-N |
| SMILES | Cl.Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@]34CC[C@H](C[C@@H]3NC(=O)[C@@H](N)CCS(C)(=O)=O)C4(C)C |
L-368,899 HYDROCHLORIDE 用途与合成方法
IC50: 8.9 nM (rat uterus oxytocin receptor), 26 nM (human uterus oxytocin receptor)
L-368,899 hydrochloride is a potent, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC 50 s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively. L-368,899 is less active on VP receptor in human liver and kidney, rat liver and kidney (IC 50 , 510 nM, 960 nM, 890 nM, 2400 nM, respectively).
L-368,899 exhibits similar pharmacokinetics in rats and dogs. After a single iv. injection, L-368,899 had a t 1/2 of 2 hr in both species. Additionally, L-368,899 has a plasma clearance between 23 and 36 ml/min/kg in rats or dogs. L-368,899 exhibits V dss values of 2.0 and 2.6 liters/kg and 3.4 to 4.9 liters/kg for dogs, respectively. L-368,899 is orally available. In the rat, at the 5 mg/kg dose, the oral bioavailabilities are 14% and 18% for female and male rats, respectively. Additionally, the oral bioavailabilities are 17% and 41% for female and male rats, respectively at the dosage of 25 mg/kg.
L-368,899 HYDROCHLORIDE 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-108677 | L-368,899 HYDROCHLORIDE | 160312-62-9 | 1mg | 1000 |
| 2026-09-15 | HY-108677 | L-368,899 HYDROCHLORIDE | 160312-62-9 | 5mg | 1900 |
